US › Healthcare

RVL Pharmaceuticals plc (RVLPQ)

US · Healthcare · Biotechnology

—

Latest quarter · ended 2023-06-30

Revenue
$8.3M
Revenue YoY
-2.2%
Net profit
$-23.9M
Profit YoY
-97.3%
EPS
$0.00
EPS estimate
$0.00
Net margin
-289.3%

Key statistics

Market cap
$1,114
Forward P/E
0.0
P/B
0.00
Book value
$0.16
EPS (TTM)
$-0.71
52-week high
$0.00
52-week low
$0.00
50-day MA
$0.00
200-day MA
$0.00
Beta
41.27

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for RVL Pharmaceuticals plc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.